Inherited mutations in DNA repair genes in men with metastatic castration-resistant prostate cancer.

被引：3
|
作者：
Nelson, Peter
Mateo, Joaquin
Beltran, Himisha
De Sarkar, Navonil
Elemento, Olivier
Rubin, Mark A.
Vinson, Jacob N.
Filipenko, Julie
Robinson, Dan R.
Chinnaiyan, Arul M.
Van Allen, Eliezer Mendel
Garofalo, Andrea
Taplin, Mary-Ellen
Garraway, Levi A.
Carreira, Suzanne
Montgomery, Robert B.
Morrissey, Colm
Cheng, Heather H.
De Bono, Johann S.
Pritchard, Colin C.
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[3] Inst Canc Res, Sutton, Surrey, England
[4] Weill Cornell Med Coll, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Univ Michigain Hlth Syst, Ann Arbor, MI USA
[7] Univ Michigan, Ann Arbor, MI 48109 USA
[8] Dana Farber Canc Inst, Boston, MA 02115 USA
[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[10] Inst Canc Res, Canc Biomarkers Lab, London, England
[11] Univ Washington Oncol, Seattle, WA USA
[12] Univ Washington, Dept Urol, Seattle, WA 98195 USA
[13] Univ Washington, Seattle, WA 98195 USA
[14] Royal Marsden NHS Fdn Trust, London, England
[15] Inst Canc Res, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5009
引用
收藏
页数：2
相关论文
共 50 条
  • [41] New Therapies for Castration-Resistant Prostate Cancer.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05) : 479 - 481
  • [42] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    Heidegger, Isabel
    Pircher, Andreas
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (09) : 890 - 891
  • [43] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    UROLOGE, 2020, 59 (06): : 673 - 679
  • [44] Management of Metastatic Castration-Resistant Prostate Cancer
    Srinivas, Sandy
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 614 - 616
  • [45] Predictors of germline DNA damage repair gene mutations (gDDRm) in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).
    Yip, Steven
    Sunderland, Katherine
    Beigi, Arshia
    Angeles, Arkhjamil
    Khalaf, Daniel
    Warner, Evan W.
    Vandekerkhove, Gillian
    Sun, Sophie
    Annala, Matti
    Wyatt, Alexander William
    Chi, Kim N.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [46] Correlation between genomic alterations and germline mutations in men with metastatic castration-resistant prostate cancer (mCRPC)
    Llacer Perez, C.
    Oliva Fernandez, L.
    Canada-Higueras, E.
    Saez, M. I.
    Villatoro, R.
    Montesa Pino, A.
    Herrera Imbroda, B.
    Hernandez, D.
    Lozano Mejorada, R.
    Romero Laorden, N.
    Marquez, M.
    Grau, G.
    Pineda, A.
    Lopez, F. J.
    Peinado, P.
    Alameda, D.
    Olmos, D.
    Castro, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S641 - S642
  • [47] Cabazitaxel in metastatic castration-resistant prostate cancer
    Yap, Timothy A.
    Pezaro, Carmel J.
    de Bono, Johann S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1129 - 1136
  • [48] Effect of germline DNA repair gene mutations on outcomes in men with metastatic castration-resistant prostate cancer receiving first-line abiraterone and enzalutamide.
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Luber, Brandon
    Wang, Hao
    Chen, Yan
    Silberstein, John
    Piana, Danilo
    Lai, Zhao
    Chen, Yidong
    Isaacs, William B.
    Luo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [49] Rucaparib in castration-resistant, metastatic prostate cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2024, 55 (02) : 96 - 98
  • [50] SPOP mutation as a predictive marker for treatment of metastatic castration-resistant prostate cancer.
    Stangl, Andrew
    Willner, Christopher
    Maahs, Lucas
    Burmeister, Charlotte
    Hwang, Clara
    Pilling, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
12345